Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

MGMT

  • You have access
    Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma
    MOONSIK KIM, JIHWAN YOO, JONG HEE CHANG and SE HOON KIM
    Anticancer Research January 2022, 42 (1) 335-341; DOI: https://doi.org/10.21873/anticanres.15490
  • You have access
    Probing the Oncolytic and Chemosensitizing Effects of Dihydrotanshinone in an In Vitro Glioblastoma Model
    VARUN KUMAR, DANIEL RADIN and DONNA LEONARDI
    Anticancer Research November 2017, 37 (11) 6025-6030;
  • You have access
    Analysis of Association Between MGMT and p53 Gene Single Nucleotide Polymorphisms and Laryngeal Cancer
    YAYUN LV, CHUANLIANG JIA, AIHUA JIANG, HUA ZHANG, YUNQIANG WANG, FEIFEI LIU, LINLIN YANG, YAN SUN, RUNLI LV and XICHENG SONG
    Anticancer Research August 2017, 37 (8) 4399-4403;
  • You have access
    Impact of Therapy Sequence with Alkylating Agents and MGMT Status in Patients with Advanced Neuroendocrine Tumors
    SEBASTIAN KRUG, MICHAEL BOCH, PETER REXIN, THOMAS M. GRESS, PATRICK MICHL and ANJA RINKE
    Anticancer Research May 2017, 37 (5) 2491-2500;
  • You have access
    Predictive Biomarkers to Chemotherapy in Patients with Advanced Melanoma Receiving the Combination of Cisplatin - Vinblastine - Temozolomide (PVT) as First-line Treatment: A Study of the Hellenic Cooperative Oncology Group (HECOG)
    HELENA LINARDOU, GEORGE PENTHEROUDAKIS, IOANNIS VARTHALITIS, HELEN GOGAS, DIMITRIOS PECTASIDES, THOMAS MAKATSORIS, GEORGE FOUNTZILAS, DIMITRIOS BAFALOUKOS and The Hellenic Cooperative Oncology Group
    Anticancer Research February 2015, 35 (2) 1105-1113;
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire